» Articles » PMID: 36835469

Genotoxicity of Novel Pyrazolo[4,3-]tetrazolo[1,5-][1,2,4]triazine Sulfonamides in Normal and Cancer Cells In Vitro

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2023 Feb 25
PMID 36835469
Authors
Affiliations
Soon will be listed here.
Abstract

Pyrazolo[4,3-]tetrazolo[1,5-][1,2,4]triazine sulfonamides constitute a novel group of heterocyclic compounds with broad biological activities including anticancer properties. The compounds investigated in this study (, , , and ) were found to have antiproliferative activity against BxPC-3 and PC-3 cancer cell lines in micromolar concentrations (IC 0.11-0.33 µM). Here, we studied the genotoxic potential of the tested compounds with alkaline and neutral comet assays, accompanied by immunocytochemical detection of phosphorylated γH2AX. We found that pyrazolo[4,3-]tetrazolo[1,5-][1,2,4]triazine sulfonamides induce significant levels of DNA damage in BxPC-3 and PC-3 cells without causing genotoxic effects in normal human lung fibroblasts (WI-38) when used in their respective IC concentrations (except for ) and showed a dose-dependent increase in DNA damage following 24 h incubation of tested cancer cells with these agents. Furthermore, the influence of compounds on DNA damage response (DDR) factors was assessed using molecular docking and molecular dynamics simulation.

Citing Articles

Pyrazolo[4,3-]tetrazolo[1,5-][1,2,4]triazine Sulfonamides as an Important Scaffold for Anticancer Drug Discovery-In Vitro and In Silico Evaluation.

Kciuk M, Marciniak B, Celik I, Zerroug E, Dubey A, Sundaraj R Int J Mol Sci. 2023; 24(13).

PMID: 37446136 PMC: 10342037. DOI: 10.3390/ijms241310959.

References
1.
Sun S . Searching for the real function of mTOR signaling in the regulation of PD-L1 expression. Transl Oncol. 2020; 13(12):100847. PMC: 7451686. DOI: 10.1016/j.tranon.2020.100847. View

2.
Corvi R, Madia F . In vitro genotoxicity testing-Can the performance be enhanced?. Food Chem Toxicol. 2016; 106(Pt B):600-608. DOI: 10.1016/j.fct.2016.08.024. View

3.
Haystead T . The purinome, a complex mix of drug and toxicity targets. Curr Top Med Chem. 2006; 6(11):1117-27. DOI: 10.2174/156802606777812059. View

4.
Rampersad S . Multiple applications of Alamar Blue as an indicator of metabolic function and cellular health in cell viability bioassays. Sensors (Basel). 2012; 12(9):12347-60. PMC: 3478843. DOI: 10.3390/s120912347. View

5.
Choi J, Berdis A . Combating resistance to DNA damaging agents. Oncoscience. 2018; 5(5-6):134-136. PMC: 6049302. DOI: 10.18632/oncoscience.423. View